June 11, 2024European Journal of Preventive CardiologyOpen Access

Use of combination therapy is associated with improved LDL cholesterol management: 1-year follow-up results from the European observational SANTORINI study

View Full Paper

Ask AI

Bookmark

Achievement of low density lipoprotein cholesterol targets improved markedly with lipid lowering therapy, driven by the increased adoption of combination therapy.
Goal attainment reached 39.4% with combination therapy compared with 25.5% for monotherapy, reflecting substantial improvements across high cardiovascular risk patients.
Prospective follow-up in the observational SANTORINI study across 14 European countries highlights that wider combination therapy is required to overcome persistent target gaps.

Discussion

No takes yet. Share an insight, caveat, or question.

Implication

Observational study demonstrates improved lipid goal attainment with combination therapy in high-risk patients, highlighting the need for broader treatment escalation.

Cite This Study

Ray et al. (2024) studied this question.

synapsesocial.com/papers/68e6541cb6db6435875e2bf2 https://doi.org/10.1093/eurjpc/zwae199

View Full Paper

Ask AI

Bookmark

Implication

Observational study demonstrates improved lipid goal attainment with combination therapy in high-risk patients, highlighting the need for broader treatment escalation.

Use of combination therapy is associated with improved LDL cholesterol management: 1-year follow-up results from the European observational SANTORINI study

Key Points

Discussion

Implication

Cite This Study

Use of combination therapy is associated with improved LDL cholesterol management: 1-year follow-up results from the European observational SANTORINI study

Key Points

Discussion

Implication

Cite This Study

Also Consider

Also Consider